Instil Bio Stock Analysis

Instil Stock Analysis Notes

About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.03. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Instil Bio recorded a loss per share of 18.39. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 8th of December 2023. Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas. Instil Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 463 people. To find out more about Instil Bio contact Bronson Crouch at 972 499 3350 or learn more at https://instilbio.com.

Instil Bio Investment Alerts

Instil Bio Upcoming and Recent Events

Instil Largest EPS Surprises

View All Earnings Estimates

Instil Bio Environmental, Social, and Governance (ESG) Scores

Instil Stock Institutional Investors

Note, although Instil Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Instil Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 200.58 M.

Instil Profitablity

Management Efficiency

Instil Bio has Return on Asset of (0.1245) % which means that on every $100 spent on assets, it lost $0.1245. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.4865) %, meaning that it generated no profit with money invested by stockholders. Instil Bio's management efficiency ratios could be used to measure how well Instil Bio manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.5. The value of Return On Capital Employed is expected to slide to -0.3. At this time, Instil Bio's Total Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 670.4 M this year, although the value of Other Current Assets will most likely fall to about 6 M.

Technical Drivers

As of the 11th of November 2024, Instil Bio retains the Downside Deviation of 7.44, risk adjusted performance of 0.1264, and Market Risk Adjusted Performance of 0.561. Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Instil Bio, as well as the relationship between them. Please check out Instil Bio jensen alpha and downside variance to decide if Instil Bio is priced fairly, providing market reflects its last-minute price of 30.84 per share. Given that Instil Bio has jensen alpha of 1.73, we strongly advise you to confirm Instil Bio's regular market performance to make sure the company can sustain itself at a future point.

Instil Bio Price Movement Analysis

Instil Bio Insider Trading Activities

Instil Bio Outstanding Bonds

Instil Bio Predictive Daily Indicators

Instil Bio Corporate Filings

Instil Bio Forecast Models

Instil Bio's time-series forecasting models are one of many Instil Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Instil Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Instil Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Instil shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Instil Bio. By using and applying Instil Stock analysis, traders can create a robust methodology for identifying Instil entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Instil analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Instil analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Instil Bio stock analysis indicators help investors evaluate how Instil Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Instil Bio shares will generate the highest return on investment. By understating and applying Instil Bio stock analysis, traders can identify Instil Bio position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.